Psychiatric Groups Urge FDA to Monitor Effects of Antidepressant Warning

Drug Industry Daily
KEYWORDS FDA / Rx
A A

The FDA’s warnings last fall about links between antidepressant use and adolescent suicidal behavior may have spurred a “swift and steep” decline in the number of pediatric prescriptions for the treatments, according to psychiatric groups.

To View This Article:

Login

Subscribe To Drug Industry Daily